Medtronic sales and marketing update

FDA classified as a class I recall the corrections made by Medtronic to the product labeling for its SynchroMed II pump and SynchroMed EL Implantable Infusion pump to warn against the occurrence of pocket fills. A pocket fill is the inadvertent injection during a refill procedure of all or some of the prescribed drug into the patient's subcutaneous tissue instead of the pump which can cause life threatening injuries or death. ...